UT Southwestern Medical Center
Experimental drug shows promise against brain, prostate cancers
Published in Cancer Weekly, January 19th, 2010
The drug's actions, observed in isolated human cells in one trial and in rodents in the other, are especially encouraging because they attacked not only the bulk of the tumor cells but also the rare cancer stem cells that are believed to be responsible for most of a cancer's growth, said Dr. Jerry Shay, professor of cell biology and a senior co-author of both papers. The glioblastoma study appears in the January issue of Clinical Cancer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-01-19)
More Articles from Cancer Weekly
- American College of Radiology / American Roentgen Ray Society
New SBI and ACR recommendations suggest breast cancer screening should begin at age 40 - American Society for Gastrointestinal Endoscopy
Study examines interval colorectal cancer despite surveillance colonoscopy - American Society for Radiation Oncology
Sexual function does not continuously decline after radiation therapy treatments for prostate cancer - Biotechnology and Biological Sciences Research Council
New insights into mushroom-derived drug promising for cancer treatment - University of Iowa
Unusual protein modification involved in muscular dystrophy, cancer - Wiley-Blackwell
Caffeine consumption associated with less severe liver fibrosis - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
